मैट्रिक्स
 
 
moneycontrol.com भारत | लेखांकन नीति > Hotels > लेखांकन नीति फॉलोड से विश्व विशाल इंजीनियरिंग लिमिटेड - बीएसई: 512321, NSE: N.A

विश्व विशाल इंजीनियरिंग लिमिटेड

बीएसई: 512321  |  NSE: N.A  |  ISIN:  |  Hotels

खोजें विश्व विशाल इंजीनियरिंग लिमिटेड कनेक्शन मार्च 09
लेखांकन नीति साल : मार्च '10
i) GENERAL:

The accounts have been prepared on historical cost convention and according to the generally accepted accounting principles and on accrual basis of accounting except otherwise stated.

ii) FIXED ASSETS:

Fixed Assets have been stated at acquisition/construction cost, which includes Freight, Insurances, Taxes and installation expenses less accumulated depreciation till date. Profit or Loss on disposal of Fixed Assets is recognized in the Profit and Loss Accounts.

iii) REVENUE RECOGNITION

sales exclude excise duty & sale tax. Incentive bonus received and penalty charged are accounted on accrual basis.

iv) INVESTMENTS

Investments have been stated at cost.

vi) DEPRECIATION

The Company has provided depreciation on Pro-rata basis on written down value method at the lattes specified in Schedule XIV to the Companies Act 1956. Assets below Rs, 5000/- have been depreciated in full. Leasehold lands have been amortized over the period 99 years i.e. period of lease in equal instalments

v)Taxation:

Current Tax is determined as the amount of tax payable in respect On taxable income for the year. Deferred tax is sublet to consideration old prudence, on timing differences, being difference between lax able and Accounting income/expenditure that originate in one period and aye capable of reversal in one or more subsequent pained(s)

स्रोत: रेलीगरे टेचनोवा

न्यूज़ फ़्लैश

  • MARKET CUES : FIIs ने कैश में `356 Cr की खरीदारी की
  • MARKET CUES : DIIs ने कैश में `1704 Cr की खरीदारी की
  • MARKET CUES : FIIs ने F&O में `802 Cr की खरीदारी की
  • MARKET CUES : इंडेक्स फ्यूचर्स में `29 Cr की बिकवाली
  • MARKET CUES : इंडेक्स ऑप्शंस में `336 Cr की खरीदारी
  • MARKET CUES : स्टॉक फ्यूचर्स में `482 Cr की खरीदारी
  • CS ON PHARMA : Limited Upside की वजह से Neutral रेटिंग
  • CS ON PHARMA : FY21 के लिए आय लक्ष्य घटाकर 5%
  • CS ON PHARMA : FY22 के लिए आय लक्ष्य घटाकर 6%
  • CS ON PHARMA : Sun Pharma: लक्ष्य `450 से घटाकर `400/Sh

अभी देखें

मॉर्निंग कॉल

OUR WINNING PICKS

DID YOU INVEST?

INTRADAY PICKS!

(August 06, 2018)

AT (Rs)



GAIN (Rs)

ALL TIME WINNERS

RECO PRICE

PEAK PRICE

OUR PACKAGES

Super Combo

Powerful mix of both trader and investor packs with timely expert advice.

Technical

Designed especially for traders looking to tap the profit opportunities of volatile markets.

Fundamental

For all investors looking to unearth stocks that are poised to move.